id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-288331-n0n69axw	Ozturk, Ayse Bilge	Change in Allergy Practice during the COVID-19 Pandemic	2020-10-15		.txt	text/plain	1940	106	39	Thirty-four percent of the physicians reported interruption of systemic steroid use in asthma patients, and 25% of the respondents discontinued biological therapy. Allergy and immunology clinics rapidly coordinated changes according to the guidelines' recommendations for the COVID-19 pandemic while trying to meet academic/health care needs in addition to providing safety to medical staff and patients. Participants were using national and international societies' guidelines and online services such as those of the TNSACI, the European Academy of Allergy and Clinical Immunology (EAACI), the World Allergy Organization (WAO), and the Global Initiative for Asthma (GINA) as resources for COVID-19 [1] [2] [3] [4] [5] . Similarly, available international guidelines including the current EAACI statement recommend continuing biologicals for the treatment of asthma during COVID-19 and report that there is no current evidence to suggest that biologicals for the treatment of asthma increase the risk of CO-VID-19 infection; biological therapy was discontinued in one fourth of the asthma patients in our allergy clinics [10] .	./cache/cord-288331-n0n69axw.txt	./txt/cord-288331-n0n69axw.txt